These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Effect of electroacupuncture scalp point-through-point therapy on the expression of tyrosine hydroxylase and dopamine transporter mRNAs in substantia nigra of Parkinson's disease model rats]. Wang S; Qi XJ; Han D Zhongguo Zhen Jiu; 2009 May; 29(5):391-4. PubMed ID: 19489498 [TBL] [Abstract][Full Text] [Related]
43. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Kastner A; Hirsch EC; Agid Y; Javoy-Agid F Brain Res; 1993 Mar; 606(2):341-5. PubMed ID: 8098254 [TBL] [Abstract][Full Text] [Related]
44. Effect of increasing doses of intracaudate haloperidol upon motor expressions that require an intact substantia nigra pars reticulata and/or superior colliculus in cats. Gelissen M; Cools A Behav Brain Res; 1988 Mar; 27(3):205-14. PubMed ID: 3358859 [TBL] [Abstract][Full Text] [Related]
45. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease. Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171 [TBL] [Abstract][Full Text] [Related]
46. A single (-)-nicotine injection causes change with a time delay in the affinity of striatal D2 receptors for antagonist, but not for agonist, nor in the D2 receptor mRNA levels in the rat substantia nigra. Li XM; Zoli M; Finnman UB; Le Novère N; Changeux JP; Fuxe K Brain Res; 1995 May; 679(1):157-67. PubMed ID: 7648259 [TBL] [Abstract][Full Text] [Related]
47. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion. Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981 [TBL] [Abstract][Full Text] [Related]
48. Effects of haloperidol and melatonin on the in situ activity of nigrostriatal tyrosine hydroxylase in male Syrian hamsters. Vriend J; Dreger L Life Sci; 2006 Mar; 78(15):1707-12. PubMed ID: 16263138 [TBL] [Abstract][Full Text] [Related]
49. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain. Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466 [TBL] [Abstract][Full Text] [Related]
50. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata. Celada P; Paladini CA; Tepper JM Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615 [TBL] [Abstract][Full Text] [Related]
51. (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in unanesthetized rats. Mereu G; Casu M; Gessa GL Brain Res; 1983 Mar; 264(1):105-10. PubMed ID: 6133578 [TBL] [Abstract][Full Text] [Related]
53. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats. Wang YQ; Bian GL; Bai Y; Cao R; Chen LW Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597 [TBL] [Abstract][Full Text] [Related]
54. Role of the substantia nigra pars reticulata in sensorimotor gating, measured by prepulse inhibition of startle in rats. Koch M; Fendt M; Kretschmer BD Behav Brain Res; 2000 Dec; 117(1-2):153-62. PubMed ID: 11099769 [TBL] [Abstract][Full Text] [Related]
55. Inhibition of non-dopamine cells in the ventral tegmental area by benzodiazepines: relationship to A10 dopamine cell activity. O'Brien DP; White FJ Eur J Pharmacol; 1987 Oct; 142(3):343-54. PubMed ID: 2892684 [TBL] [Abstract][Full Text] [Related]
56. EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity. Richards AB; Scheel TA; Wang K; Henkemeyer M; Kromer LF Eur J Neurosci; 2007 May; 25(9):2619-28. PubMed ID: 17561836 [TBL] [Abstract][Full Text] [Related]
57. Two-color immunohistochemistry for dopamine and GABA neurons in rat substantia nigra and zona incerta. Oertel WH; Tappaz ML; Berod A; Mugnaini E Brain Res Bull; 1982; 9(1-6):463-74. PubMed ID: 6129046 [TBL] [Abstract][Full Text] [Related]
58. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons. Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967 [TBL] [Abstract][Full Text] [Related]
59. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. Han M; Huang XF; Deng C Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411 [TBL] [Abstract][Full Text] [Related]
60. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms. Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]